* Department of Dermatology, School of Medicine, State University of New York, Stony Brook, New York 11794-8165; and Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Normal adult human dermal fibroblasts
grown in a three-dimensional collagen lattice increase
mRNA level of collagen receptor integrin subunit 2
(Xu, J., and R.A.F. Clark. 1996. J. Cell Biol. 132:239-
249.) and DNA binding activity of a nuclear transcription factor, NF-
B (Xu, J., and R.A.F. Clark. 1997. J. Cell Biol. 136:473-483.). Here we present evidence that
the collagen lattice induced the nuclear translocation of
p50, one member of NF-
B family, and the degradation
of an NF-
B inhibitor protein, I
B-
. The inhibition of
NF-
B activity by SN50, a peptide inhibitor targeted at
nuclear translocation of NF-
B, significantly reduced
the induction of integrin
2 mRNA and protein by the
collagen lattice. A region located between
549 and
351 bp in the promoter of integrin
2 gene conferred
the inducibility by three-dimensional collagen lattice.
The presence of either SN50 or I
B-
32, 36, a stable mutant of I
B-
, abrogated this inducibility, indicating that the activation of integrin
2 gene expression was
possibly mediated by NF-
B through this region. Although there were three DNA-protein binding complexes forming in this region that are sensitive to the inhibition of NF-
B nuclear translocation, NF-
B was
not directly present in the binding complexes. Therefore, an indirect regulatory mechanism by NF-
B in integrin
2 gene expression induced by three-dimensional
collagen lattice is suggested. The involvement of NF-
B
in reorganization and contraction of three-dimensional
collagen lattice, a process that requires the presence
of abundant integrin
2
1, was also examined. The inhibition of NF-
B activity by SN50 greatly blocked the
contraction, suggesting its critical role in not only the
induction of integrin
2 gene expression by three-
dimensional collagen lattice, but also
2
1-mediated tissue-remodeling process.
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
THREE-DIMENSIONAL (3D)1 extracellular matrix (ECM)
culture systems have been developed to simulate
natural interactions between cells and ECM environment. Fibroblasts cultured in type I collagen matrix can
exert forces sufficient to contract the hydrated lattice into
dense organized structures resembling dermis. The alignment of collagen fibers that occurs during the embryonic
formation of tendons and ligaments and the contraction of
collagenous tissue that occurs in healing wounds are
thought to be under the influence of the same forces (for
review see Grinnell, 1994). Accompanying is the altered
expression of a group of genes including integrin
2 (Klein
et al., 1991
), type I matrix metalloproteinase (MMP-1; Langholz et al., 1995
), and type I collagen (Eckes et al.,
1993
) in these fibroblasts. Therefore, 3D collagen lattice
(COL) may elicit unique signaling processes leading to the
altered expression of related genes and the ability of fibroblasts to mediate tissue remodeling.
Integrin 2
1 is a heterodimeric adhesive protein receptor belonging to the
1 subfamily. It serves as a collagen
receptor on fibroblasts and platelets and additionally as a
laminin receptor on epithelial and endothelial cells (Elices
and Hemler, 1989
; Languino et al., 1989
; Kirchhofer et al.,
1990
). Functions mediated by
2
1 may include cell differentiation, motility and metastasis (Chan et al., 1991
; Skinner et al., 1994
; Keely et al., 1995
; Zutter et al., 1995a
; Doerr and Jones, 1996
). For example, the loss of
2
1 in
breast epithelial cells is correlated with the transformed
phenotype (Keely et al., 1995
; Zutter et al., 1995a
). The interaction of
2
1 integrin with extracellular type I collagen in a 3D polymerized structure has been reported to result
in the reorganization and contraction of a hydrated collagen matrix (Schiro et al., 1991
), and the increased expression of MMP-1 (Riikonen et al., 1995a
).
The expression of 2
1 is a regulated cellular process. In
addition to 3D COL, the regulatory signals for
2
1 integrin expression include PDGF (Ahlen and Kristofer,
1994
), TGF-
(Riikonen et al., 1995b
), EGF (Fujii et al.,
1995
), PMA (Xu et al., 1996
), and oncogenes Erb-B2 and
v-ras (Ye et al., 1996
). The mechanisms underlying the
2
1 expression stimulated by 3D COL remain unclear.
Previously we have presented evidence that a second messenger pathway elicited by 3D COL, which involves protein kinase C-
, can mediate integrin
2 mRNA expression (Xu and Clark, 1997
). A recent report showed that
other second messenger proteins are modulated by 3D
COL such as the suppression of p70 S6 kinase and the elevated levels of p27Kip1 and p21Cip1/Waf1, inhibitors of cyclin-dependent kinase 2 (cdk2) (Koyama et al., 1996
). The 3D
COL was also reported to regulate the transcription machinery. For example, the transcription of collagen (Eckes
et al., 1993
) and albumin (Caron, 1990
) genes is downregulated by 3D COL. The DNA binding activity of nuclear
transcription factors has been found to be directly regulated by 3D COL. Nuclear extracts of hepatocytes cultured in 3D COL demonstrated induction of DNA binding
activity to a TGTTTGC sequence that occurs at regulatory sites of several hepatic genes including albumin, a 3D COL-
responsive gene (DiPersio et al., 1991
; Liu et al., 1991
). We
showed previously that fibroblasts cultured in 3D COL increased DNA binding activity of nuclear factor (NF)-
B
(Xu and Clark, 1997
), a transcription factor that activates
gene transcription by binding to a
B sequence motif in
the promoter of responsive genes after release from an inactive cytoplasmic complex and translocation to the nucleus (for review see Baeuerle and Baltimore, 1996
).
A number of studies have addressed the intimate association between the NF-B/Rel family of transcription factors
and cell adhesion events. First, activation of NF-
B can be
caused by the adhesion of cells to fibronectin including
human gingival fibroblasts, monkey smooth muscle cells
(Qwarnstrom et al., 1994
), and human monocytic cell line
THP-1 (Lin et al., 1995a
). The cell-binding domain and the
heparin-binding domain of fibronectin molecule were reported to mediate the NF-
B activation (Qwarnstrom et al., 1994
). Integrins are considered a critical player in this process since the ligation to
1 integrins to antibody also
induces NF-
B activity comparable to cell adhesion to fibronectin (Lin et al., 1995a
). Second, NF-
B activity is required for the expression of a group of genes encoding
cells adhesion molecules such as vascular cell adhesion
molecule-1 (VCAM-1), E-selectin, intercellular adhesion
molecule-1, and mucosal addressin cell adhesion molecule-1 (for review see Baldwin, 1996
). VCAM-1, a cell surface protein typically found on endothelial cells upon stimulation by tumor necrosis factor (TNF)-
, interleukin
(IL)-1, or lipopolysaccharide, binds circulating monocytes
and lymphocytes expressing
4
1 or
4
7 integrins and
likely participates in the recruitment of these cells to sites
of tissue injury (Elices et al., 1990
; Chan et al., 1992
). Additionally, NF-
B seems directly involved in the adhesion
of murine embryonic stem cells to various ECM such as gelatin, fibronectin, laminin, and type IV collagen. Antisense RelA oligonucleotides (and in some instances antisense p50 oligonucleotides) administered to various cells,
including embryonal stem cells, cause complete detachment from the substratum (Narayanan et al., 1993
; Sokoloski et al., 1993
). Also, PMA-induced adhesion of HL-60 cells could be inhibited by competitive binding of NF-
B
in vivo (Eck et al., 1993).
Little is known about the reciprocal regulation between
NF-B and 3D ECM. In the present study, we characterized the activation of NF-
B and its role in integrin
2
gene expression by 3D COL. We show in this report that
the 3D COL can induce the nuclear translocation of p50,
that NF-
B activity was required for the induction of integrin
2 expression by 3D COL at promoter activity, steady-state mRNA level, and protein level, and that a promoter region conferred 3D COL inducibility. Finally, we demonstrate that NF-
B activity appeared to be required for fibroblast-mediated contraction of 3D collagen matrices.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell Culture and Reagents
Human fibroblast cultures established by outgrowth from healthy human
skin biopsies were provided by M. Simon (SUNY, Stony Brook, NY). The
cells were maintained in DME (GIBCO-BRL, Gaithersburg, MD), supplemented with 10% FCS (Hyclone, Logan, UT), 100 U/ml penicillin, 100 U/ml streptomycin (GIBCO-BRL), and grown in a humidified atmosphere
of 5% CO2 and 95% air at 37°C. Cells between population doubling levels
15 and 20 (the 6th and 10th passage) were used for the experiments. Bisindolylmaleimide GF 109203X (BIM) was purchased from CalBiochem-Novabiochem Corp. (La Jolla, CA). SN50 was obtained from BIOMOL
(Plymouth Meetings, PA). The control peptide of SN50, SM, was synthesized by Research Genetics Inc. (Huntsville, AL) based on published sequences (Lin et al., 1995b). Polyclonal antibodies against NF-
B p65, p50,
c-Rel, RelB, I
-B
, and monoclonal antibody against Sp1 were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against
-tubulin and human integrin
2 subunit were purchased from Chemicon International, Inc. (Temecula, CA). [14C]Chloramphenical, [
-32P]dCTP,
and [
-32P]ATP were obtained from DuPont-NEN (Boston, MA).
Plasmids and Oligonucleotides
Plasmids basicCAT and cytomegalovirus-CAT have been described previously (Zutter et al., 1994). Plasmids RSV-
-galactosidase, human
2
cDNA probe, wild-type I
B-
, and constitutive I
B-
32, 36 were provided
by L. Taichman (SUNY), Y. Takada (The Scripps Institute, La Jolla, CA)
(Takada and Hemler, 1989
), W. Greene (The Gladstone Institute of Virology and Immunology), respectively. Human MMP-1 cDNA and
5
cDNA were purchased from American Type Culture Collection (Rockville, MD) and GIBCO-BRL, respectively. An oligonucleotide complementary to 28S ribosomal RNA was purchased from CLONTECH (Palo
Alto, CA). NF-
B and Sp1 enhancer element consensus sequences 5
-AGT TGA GGG GAC TTT CCC AGG C-3
and 5
-ATT CGA TCG
GGG CGG GGC GAG C-3
, respectively, were purchased from Promega
Corp. (Madison, WI). The four repeats of NF-
B consensus element (GGGACTTTCC) as well as four repeats of its mutated sequence (ATCACTTTCC; mutated bases are underlined) were synthesized and inserted, respectively, into the BamHI site of a promoter-CAT vector
purchased from Promega Corp. The construction of a series of
2CAT
plasmids has been described previously (Zutter et al., 1994
). For the opposite orientation of an upstream sequence of
2 promoter (
549 through
351), the DNA fragment was digested with restriction enzymes (BglII
and SmaI), filled in at 3
end, and ligated back into the vector. Deletion
mutant, p
2549.dis, was made by restriction enzyme digestion of fragments (
351 through
122 by SmaI and SacII) from p
2549CAT. A second deletion mutant, p
2549.del, was made by removing a fragment (
549 though
351) from p
2776CAT by BglII and SmaI followed by filling in and ligation. For SV-40 promoter-CAT constructs, the
2 promoter
fragment (
549 through
351) in both orientations was inserted into the
BamHI site of the vector. The correctness of the recombinant DNA work
was confirmed through restriction digest analysis. The PCR protocol for
generating promoter fragments used in DNA-protein binding reaction
was as follows: 20 ng of DNA template was amplified at 94°C for 2 min,
followed by 30 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 30 s in
a programmable thermal controller (PTC-100, Model 60; MJ research,
Watertown, MA). The sequences of primers used are: pair 1 (5
-
590GTATTGCTTAAATATCA
573-3
; 5
-
514AGGTTAGAAACTAACTC
531-3
); pair 2 (5
-
516CTGGTCATTCTGCGCTTA
498-3
; 5
-
413CACTAGCCCTAAACCACA
431-3
); and pair 3 (5
-
415GTGCCCTCGGACCCCGCT
397-3
; 5
-
342AGTCCCCGGGAGAACGTG
360-3
).
Preparation of COLs
Collagen gels were prepared according to a procedure previously described (Xu and Clark, 1996). Pepsin-solubilized bovine dermal collagen
dissolved in 0.012 M HCl was 99.9% pure containing 95-98% type I collagen and 2-5% type III collagen (Vitrogen 100; Celltrix Laboratories,
Palo Alto, CA). Collagen for cultures was prepared by mixing 2.0 mg/ml
of type I collagen, 100 U/ml penicillin, 100 U/ml streptomycin, and 1%
FCS in DME, pH 7.0-7.4. Human dermal fibroblasts from subconfluent
cultures starved in 1% FCS for 24 h were mixed with collagen solution for
a final concentration of 5 × 105 cells/ml. The collagen cell suspension (4 ml)
was immediately placed onto 2% BSA-coated (ICN Biomedicals, Aurora,
OH) between, 60-mm petri dishes (Falcon, Becton Dickinson Labware,
Lincoln Park, NJ) and incubated at 37°C for 2 h or for the time periods described in figure legends before the addition of 5 ml of 1% FCS/DME to
each dish. In most experiments described here, cells used as control are
cultured in 1% FCS/DME on conventional tissue plastic plates.
After incubation at 37°C in 95% air, 5% CO2, and 100% humidity for the indicated time, cultures were carefully washed twice in DME, and then processed for various analysis. In experiments where inhibitors were used, the levels of lactate dehydrogenase activity released were measured (LD Diagnostic kit; Sigma Chemical Co., St. Louis, MO) and were similar between cells cultured in the presence or absence of inhibitors. When gel contraction experiments were performed, the contraction process was observed and photographed at indicated time points. The surface areas of the gels were measured from prints. Data are presented as relative value and represent 10 individual experiments.
Coating of Petri Dishes
For monolayer collagen coating of plastic dishes, the collagen used for lattices was diluted to a final concentration of 50 µg/ml with PBS. This solution was added to plastic dishes at a final concentration of 6.4 µg/cm2 and incubated overnight at 4°C. Coated dishes were blocked with 2% BSA for 2 h at room temperature and rinsed with PBS twice before use.
Northern Analysis of Total Cellular RNA
Total RNA was isolated from cell monolayers and collagen gel cultures
using a modification of guanidinium thiocyanate method (Chromczynski
and Sacchi, 1987). After centrifugation at 14,000 g to remove culture medium, collagen gels were dissolved in 4 M guanidinium isothiocyanate and
repeatedly passed through a 20.5-gauge needle. For Northern blot hybridization, 3-5 µg of total RNA was treated with glyoxal/DMSO, separated
by electrophoresis on an 1% agarose gel in 10 mM phosphate buffer, pH
7.0, and then transferred to Hybond+ nylon membranes (Amersham Corp.,
Arlington Heights, IL). Ethidium bromide (0.5 µg/ml) was included in the
gel to monitor equal loading by the quantity of 18S and 28S ribosomal
RNA present. cDNA probes were labeled with [
-32P]dCTP by the random primer procedure (DuPont-NEN, Boston, MA). Oligonucleotide probes
were end labeled with [
-32P]ATP in the presence of polynucleotide kinase (Boehringer Mannheim, Indianapolis, IN). The filters were hybridized to the labeled probes in QuickHyb solution (Stratagene, La Jolla,
CA) for 3 h at 68°C and washed according to manufacturer's protocol.
The signals were detected by autoradiography (X-Omat AR; Eastman
Kodak, Rochester, NY) at
80°C for optimal exposure. All results shown
are representative of at least two independent experiments.
Western Immunoblotting
4-7 µg of proteins from cytoplasmic and nuclear fractions prepared as
previously described (Xu and Clark, 1997) were separated on SDS-polyacrylmide gel and transferred to polyvinylidene difluoride membranes
(Millipore Corp., Bedford, MA). The membranes were incubated with a
blocking solution containing 2% BSA, 2% horse serum, 50 mM Tris, pH
7.5, 150 mM NaCl, and 0.05% Tween 20 for 1 h at room temperature, and
then incubated overnight at 4°C with various primary antibodies: p50, I
-B
,
-tubulin, Sp1 and integrin
2 subunit. For detection with enhanced
chemiluminescence (Amersham Corp.), the blot was incubated with
HRP-conjugated goat anti-rabbit antibody (1:1,000 dilution; Amersham
Corp.) in 50 mM Tris, pH 7.5, 150 mM NaCl, and 0.05% Tween 20 for 1 h
at room temperature. For detection with alkaline phosphatase, the membrane was sequentially incubated with biotinylated anti-rabbit goat IgG
(H+L) (Vector Labs., Inc., Burlington, CA) at 6 µg/ml (1:250 dilution),
and alkaline phosphatase at 1:600 dilution, and then visualized by NBT/
BCIP.
Gel Mobility Shift Assay
Gel mobility shift assay was performed as previously described (Xu and
Clark, 1997). NF-
B and Sp1 recognition sequences 5
-AGT TGA GGG
GAC TTT CCC AGG C-3
and 5
-ATT CGA TCG GGG CGG GGC
GAG C-3
, respectively, were purchased (Promega, Madison, WI). These oligonucleotides as well as PCR-generated DNA fragments were end labled by [
-32P]ATP. The nuclear extracts (3-5 µg) were incubated with 1 µg poly (dI/dC) (Boehringer Mannheim) and 2 µg BSA (GIBCO-BRL) in a
binding buffer (10 mM Tris, pH 7.9, 5 mM MgCl2, 50 mM KCl, 10% glycerol, and 1-5 × 104 cpm end-labeled oligonucleotides) for 20 min at room
temperature. The samples were separated on a 5% native polyacrylamide
gel in 0.5× TBE buffer (Tris-borate-EDTA). For supershift assays, 2 µl antibodies were added to the reaction mixture containing end-labeled oligonucleotides, and then incubated for additional 30 min at room temperature. The samples were separated on a 3.5% native polyacrylamide gel.
DNA Transfection
DNA transfection was performed as previously described with a few modifications (Xu et al., 1996). Cells were passaged at 5-7 × 105 per 10-cm
plate. Transfection was performed 22-24 h after passage. Cotransfection
was performed with either two plasmids, p
2-CAT and pRSV-
gal control DNA (15 µg each plasmid), or three plasmids, wild-type or constitutive I
B-
32, 36, p
2-CAT, and pRSV-
gal control DNA (10 µg each), in
1 ml 0.25 M CaCl2 were added dropwise to 1 ml 2× HEBS (50 mM Hepes,
pH 7.05, 280 mM NaCl, 1.5 mM Na2HPO4) to form a precipitate. Cells in
plates were rinsed twice with DME. Precipitate was added to the plate and incubated for 20 min at 37°C in 5% CO2. DME containing 10% FBS
and 50 mM chloroquine was added to 10 ml. After 4 h, medium was replaced with 0.5% FCS. After 40 h, the transfected cells were trypsinized,
washed twice with PBS, and then subcultured into collagen gel or onto either tissue plastic or collagen-coated surface for 18-24 h in 0.5% FCS.
Protein extracts were prepared after cells were released from 3D COL
(Xu and Clark, 1997
), and CAT enzyme activity was analyzed as described
previously (Xu et al., 1996
).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The 3D COL Induces NF-B Activity
Previously we observed that 3D COL induces integrin 2
mRNA expression by activating protein kinase C (PKC)-
(Xu and Clark, 1997
). PKC-
has been shown to play an
essential role in activating NF-
B by dominant-negative
PKC-
blocking TNF-
-stimulated NF-
B activity and constitutively active PKC-
activating NF-
B in NIH 3T3 cells
(Diaz-Meco et al., 1993
, 1994
; Dominguez et al., 1993
; Folgueira et al., 1996
). We also obtained evidence that the DNA binding activity of NF-
B, along with the activation of
PKC-
and integrin
2 mRNA expression, is induced by 3D
COL (Xu and Clark, 1997
). Here we examined whether
3D COL can signal the induction of transactivating activity of NF-
B in human dermal fibroblasts. A
B-CAT reporter plasmid was constructed by inserting four repeats of NF-
B consensus element into an SV-40 promoter
CAT reporter plasmid vector. Fibroblasts were transfected with the plasmid followed by subculture in 3D COL.
As shown in Fig. 1 A, 3D COL induced transactivating
activity of NF-
B, consistent with the observation made in
DNA binding activity (Xu and Clark, 1997
). A control plasmid containing the mutant NF-
B recognition sequences did not demonstrate the inducibility by 3D COL (Fig. 1 A).
The composition of the NF-
B DNA-binding complex was
examined next by gel mobility supershift assay. The p50
and p65(RelA) of NF-
B family were found present in the
binding complex (Fig. 1 B). The composition of the DNA-binding complex remained unchanged during full time-course (24 h) of the induction examined (data not shown).
|
Although the precise mechanisms underlying the NF-B
induction remain unclear, it is known that the dissociation
of NF-
B from I
B, with which it is sequestered as an inactive precursor, and the translocation of NF-
B from cytoplasm to the nucleus are prerequisite for the subsequent
nuclear activity of NF-
B. To assess whether nuclear activity of NF-
B observed in Fig. 1 is secondary to its translocation, subcellular fractions from cells cultured in 3D COL
were prepared and immunoblotted for p50, one of two
subunits that were found in the DNA-binding complex
of NF-
B in response to 3D COL (Fig. 1 B). The nuclei
isolated from cells incubated in 3D COL from 30 min to 24 h
showed the presence of p50 in contrast to those from cells
grown on tissue culture (Fig. 2 A). As a control, Sp1, the
transcription factor that binds to its recognition site independent of 3D COL induction (Xu and Clark, 1997
),
showed the unchanged nuclear protein level during the
time-course of incubation in 3D COL (Fig. 2 A). The kinetics of protein levels of NF-
B inhibitory protein, I
B,
was also examined. Whereas I
-B
is not detectable in
adult dermal fibroblasts (data not shown), I
-B
was detected in the cytoplasmic fractions of quiescent cells (Fig.
2 B, lane 1). The accumulation of I
-B
markedly decreased 1 h after cells were cultured in 3D COL and then
resynthesized after 4 h (Fig. 2 B). This observation is in accord with the autoregulation of I
-B
by signals that stimulate NF-
B activation via I
-B
degradation (Sun et al.,
1993
). The detection of
-tubulin in the same sample preparations confirmed the specificity of I
-B
decrease (Fig. 2
B). Thus, a correlation was observed between 3D COL
stimulation and NF-
B activation, probably by regulating
the cellular level of I
-B
.
|
NF-B Mediates Integrin
2 mRNA Expression
Stimulated by 3D COL
Next we examined the role of NF-B in the induction of
integrin
2 mRNA expression by 3D COL. Since p50 responded to a 3D COL signal by undergoing nuclear translocation (Fig. 2 A) and forming NF-
B DNA-binding complexes (Xu and Clark, 1997
), a cell-permeable synthetic
peptide inhibitor, SN50
which carries the hydrophobic region of the signal peptide sequence from Kaposi's fibroblast growth factor (K-FGF) linked to the nuclear localization sequence (NLS) of p50 (Lin et al., 1995b
)
was used
to inhibit NF-
B activity in fibroblasts. SN50 has been reported to specifically inhibit the nuclear translocation of
NF-
B in intact cells such as murine endothelial LE-II cells
and human monocytic THP-1 cells stimulated by TNF-
and lysophosphatidic acid (LPA) (Lin et al., 1995b
). The
effectiveness of SN50 in inhibiting NF-
B activity stimulated by 3D COL in adult human dermal fibroblasts was
examined. As shown in Fig. 3 A, NF-
B DNA binding activity was inhibited by the presence of SN50 in a concentration-dependent manner. In contrast, one control peptide,
SM, which contains the same signal peptide sequence from
K-FGF linked to a random amino acid sequence instead of
p50 NLS (Lin et al., 1995b
), did not show measurable inhibitory effects on the DNA binding of NF-
B stimulated
by 3D COL (Fig. 3 A). To rule out the possibility that the
inhibition of NF-
B DNA binding by SN50 is a nonspecific
effect we examined the DNA binding ability of the SN50-treated nuclear extracts to Sp1 recognition sequence. The
treatment of fibroblasts with SN50 did not prevent Sp1
from binding to its specific sequence (Fig. 3 A).
|
We next measured integrin 2 mRNA level from cells
treated with SN50. The mRNA levels of MMP-1 and integrin
5 were measured in parallel. The 28S ribosomal
RNA was measured as control for gel loading. SN50 inhibited the mRNA levels of integrin
2 and MMP-1, but not
integrin
5 (Fig. 3 B). These results suggest that NF-
B
plays an important role in the regulation of integrin
2 and
MMP-1 expression by 3D COL.
3D COL Induces the Promoter Activity of
Integrin 2 Gene
Since NF-B is a transcription factor, the requirement of
its activity in 3D COL stimulation of integrin
2 mRNA
expression indicates that 3D COL may control the transcription of integrin
2 gene. To assess this possibility, we
examined whether 3D COL regulates the promoter activity of integrin
2 gene. The promoter region of the integrin
2 gene was cloned and a series of deletion mutants of 5
flanking sequence were inserted into a CAT reporter vector (Fig. 4 A) (Zutter et al., 1994
, 1995b
). Fibroblasts were transiently transfected with these CAT reporter constructs
followed by incubation in 3D COL or on two-dimensional
surfaces. As shown in Fig. 4 B, the reporter gene directed
by sequences upstream of
92 bp of integrin
2 promoter
(p
2122CAT, p
2351CAT, p
2549CAT, and p
2776CAT)
showed inhibited basal expression when compared to the
activity of p
292CAT (Fig. 4 B), indicating the presence of
potential silencer element(s). Upon stimuilation by 3D
COL, the upstream sequences up to
351 bp of integrin
2
promoter (p
292CAT, p
2122CAT, and p
2351CAT) did
not show a positive response. In contrast, the plasmids
containing either
549 or
776 bp of upstream sequences
(p
2549CAT and p
2776CAT) demonstrated 3D COL inducibility. Therefore a region located between
92 and
122 bp probably has negative regulatory sequences for
basal promoter activity, whereas the sequences located between
549 and
351 bp of integrin
2 promoter appear
to modulate positive response to 3D COL. For the convenience of this report, we designate this region
2549-351. To
understand whether the positive response to 3D COL is
elicited by collagen signals resident in collagen molecules
of any form or a special collagen structure, we cultured fibroblasts transfected with p
2549CAT on tissue plastic
plates, on monolayer collagen-coated plates, and in 3D COL.
Cells grown on collagen-coated plates failed to induce reporter gene activity when compared to cells grown on
plastic surface (Fig. 4 C), supporting our previous observations of
2 mRNA (Xu and Clark, 1997
). Therefore signals
from collagen in a particular 3D structure seemed responsible for the positive response of
2 promoter modulated
by
2549-351.
|
To further confirm that the positive response conferred
by 2549-351 is an enhancer-like response, we examined
2549-351 based on the classic definition of an enhancer element: orientation- and distance-independent activity. A
second set of CAT reporter plasmids were constructed
that include inverted orientation of
2549-351 (p
2549.revCAT), the altered distance of
2549-351 relative to the transcription initiation site by deletion of the sequence between
351 and
122 bp from p
2549CAT (p
2549. disCAT), and the deletion of
2549-351 from p
2776CAT
(p
2549.delCAT) (Fig. 5 A). Fibroblasts transfected with
this set of plasmids were compared to those with p
2549
CAT, the plasmid containing natural orientation of
2549-351.
3D COL induced CAT level directed from integrin
2 promoter region (p
2549) was mediated by
2549-351 since the
deletion of this region from p
2776 (p
2549.del) abrogated 3D COL inducibility of the reporter plasmid (Fig. 5 A),
confirming the inability of p
2351 to respond to 3D COL
stimulation (Fig. 4 B). The 3D COL response mediated by
2549-351 was also independent of either its orientation or
its distance to the transcription initiation site since both
reporter plasmids (p
2549.revCAT and p
2549.disCAT)
showed the similar 3D COL response compared to natural
parental reporter plasmid p
2549CAT (Fig. 5 A). Furthermore, the deletion of a region between
351 and
122 in
p
2549.disCAT did not restore the basal promoter activity
(Fig. 5 A), indicating the importance of the region between
92 and
122 in its negative regulation as demonstrated by p
2122 (Fig. 4 B).
|
To test whether 2549-351 alone is sufficient for 3D COL
induction, we examined the function of this region in a different promoter context. The
2549-351 was inserted in either natural or inverted orientation into an SV-40 promoter-CAT vector lacking of enhancer elements (Fig. 5 B).
3D COL induced CAT activity directed from the SV-40
promoter in the presence of
2549-351 in either orientation,
but failed to do so in its absence (Fig. 5 B). Taken together, these results indicate that 3D COL regulated integrin
2 gene expression at transcription level and that a promoter region between
549 and
351 bp was necessary and sufficient for the transcriptional stimulation by
3D COL to occur.
NF-B Mediates Integrin
2 Gene Transcription
Stimulated by 3D COL
The requirement of the NF-B for 3D COL induction of
2 promoter activity was investigated. Fibroblasts transfected with
2549-351-containing plasmid (p
2549CAT)
were treated with SN50 or its peptide control, SM. SN50
but not SM, inhibited CAT activity directed by
549 bp of
integrin
2 promoter stimulated by 3D COL (Fig. 6 A),
consistent with the observation made at mRNA steady-state level (Fig. 3 B). A PKC inhibitor, BIM, also inhibited
the promoter activity, supporting our previous finding that
PKC is required for integrin
2 mRNA expression induced
by 3D COL (Xu and Clark, 1997
). To further confirm the
inhibitory effects of SN50 on
2 promoter activity induced
by 3D COL, we used a second approach by cotransfection
of cells with
2 reporter plasmids and wild-type I
B-
or a
stable mutant I
B-
32, 36. Since 3D COL led to I
B-
degradation (Fig. 2 B), the I
B-
32, 36 mutant, which is resistant to induced degradation (Traenckner et al., 1995
),
could serve as a potent and specific inhibitor for NF-
B
activity (Wang et al., 1996
). As shown in Fig. 6 B, whereas
I
B-
32, 36 (I
BDN)-transfected cells did not alter their
basal promoter activity as compared with wild-type I
B-
(mock) transfected cells, they demonstrated a drastic reduction in 3D COL-induced p
2549CAT promoter activity. In contrast, the mutant I
B-
did not affect the promoter activity of either p
292CAT or p
2351CAT when
the transfected cells were cultured in 3D COL (Fig. 6 B).
Therefore it appears that NF-
B transactivating activity
was required for the
2549-351-mediated the 3D COL inducibility of integrin
2 promoter.
|
Analysis of DNA sequence in this region revealed that
a site located between 457 and
447 bp (GGGACGCACC) shares sequence homology but for one base (underlined) to the NF-
B consensus sequence GGGRNNYYCC (R indicates purine; N is any base; Y is pyrimidine) present in a set of inducible genes expressed by human
monocytic and endothelial cells (Parry and Mackman,
1994
). The oligonulceotides synthesized based on this sequence, however, mediated neither DNA-protein complex
formation as judged by gel mobility shift assay nor transactivation when inserted into an SV-40 promoter-CAT reporter vector as judged by CAT analysis of transfected
cells cultured in 3D COL (data not shown). The observation raised a possibility that
2 promoter context is required for the detection of NF-
B binding activity to the
region. Nuclear protein binding of the entire
2549-351 region was thus examined. Three DNA fragments were generated by PCR: F1,
590 and
514 bp; F2,
516 and
413 bp; and F3,
415 and
342 bp (Fig. 7 A). Gel mobility shift assay showed the formation of three specific F2-
protein complexes, which were moderately increased by
3D COL (Fig. 7 B) whereas F1 and F3 did not demonstrate the specific nuclear protein binding (data not shown). Three
approaches were taken to determine whether NF-
B was
directly involved in the F2-protein complexes. First, the
DNA binding activity of 3D COL-induced nuclear proteins to F2 region of
2 promoter was reduced to approximately basal level by the incubation of cells with SN50, the
p50 nuclear translocation inhibitor (Fig. 7 B), suggesting NF-
B activity is required for the binding complex formation. However, the competition with unlabeled NF-
B
consensus sequence did not affect the DNA complex formation on F2 (data not shown), suggesting the absence of
direct contact of NF-
B with this DNA fragment. Third,
supershift assays with antibodies against various proteins
of NF-
B family did not yield band shifts (data not shown), supporting the failure of NF-
B to bind this promoter region. Therefore, NF-
B appears to play a critical role in integrin
2 promoter activation by 3D COL through
2549-351
without direct binding to the region.
|
NF-B Mediates Collagen Gel Contraction
It has been reported by various laboratories that integrin
2
1 mediates reorganization and contraction of collagen
gels by human cells including fibroblasts (Schiro et al.,
1991
), cutaneous squamous carcinoma cells (Fujii et al.,
1995
), retinal pigment epithelial cells (Kupper and Ferguson, 1993
), and transformed osteosarcoma cells (Riikonen
et al., 1995). It was proposed that stimulants such as EGF
(Fujii et al., 1995
) and TGF-
(Riikonen et al., 1995b
) induce 3D COL contraction by increasing integrin
2
1 expression. The transfection of integrin
2 cDNA into a cell line RD cells that expresses
1 chain but possess a very low
level of
2
1 integrin restores the ability of RD cells to
contract collagen gels (Schiro et al., 1991
). We hypothesized that since NF-
B mediated
2 gene expression, it
may be in the regulatory pathway leading to
2-mediated
collagen gel contraction. The effects of NF-
B on 3D COL
contraction by fibroblasts were examined. Treatment of
cells with SN50, but not SM, significantly slowed the contraction process during 72 h examined (Fig. 8, A and B).
The expression of integrin
2 protein by fibroblasts cultured in 3D COL was similarly reduced by SN50 but not
SM (Fig. 8 C). The amount of a nonspecific band of low
molecular weight, serving as an internal control, was similar in all conditions (Fig. 8 C), confirming the specificity of
the inhibtion. Therefore, it further indicates that NF-
B
was involved in the integrin
2 gene expression stimulated
by 3D COL and tissue reorganization possibly by maintaining cellular level of integrin
2.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We report here that NF-B activity mediated the expression of integrin
2 gene induced by 3D COL and the contraction of 3D COL populated by adult human dermal fibroblasts. The conclusion is supported by four lines of
evidence described in this report. First, 3D COL induced
nuclear translocation of p50, an NF-
B subunit, and the
degradation and resynthesis of I
B-
(Fig. 2, A and B), an
inhibitory protein of NF-
B and an NF-
B-responsive
gene product (LeBail et al., 1993
; Chiao et al., 1994
). Second, two inhibitors of NF-
B activity, a nuclear translocation inhibitor, SN50, and a stable I
B-
mutant, I
B-
32, 36,
both reduced
2 promoter activity that resides in the upstream region between
549 and
351 bp (Fig. 6, A and
B). Third, SN50 weakened the protein complex formation
in an
2 promoter fragment from
516 to
413 bp (Fig. 7 B).
Fourth, SN50 reduced both
2 mRNA (Fig. 3 B) and protein levels (Fig. 8 C), and slowed down the collagen gel
contraction process (Fig. 8 B). The observation that 3D
COL signaled induction of NF-
B activity is in line of evidence from other laboratories that cell-ECM interactions
are associated with activation of NF-
B (Qwarnstrom et
al., 1994
; Lin et al., 1995a
; Lofquist et al., 1995
) or liver
transcription factors (Liu et al., 1991
).
The modulation in I-B
kinetics presents a potentially
critical link between cytosolic regulatory events and nuclear transcription in response to 3D COL induction. Like
cytokine, phorbol ester, and lipopolysaccharide, which
stimulate myeloid, epithelial, and fibroblast cells (Beg and
Baldwin, 1993
; Brown et al., 1993
; Cordle et al., 1993
; Henkel et al., 1993
; Sun et al., 1993
), 3D COL induces the degradation and subsequence resynthesis of I
-B
(Fig. 2 B). Thus 3D COL may be listed as another extracellular signal
that elicits an array of intracellular signal transmitters
leading to posttranslational modification of I
-B
with an
eventual consequence of NF-
B activation. I
-B
has been
known as a target of many intracellular signals such as tyrosine phosphorylation events (Imbert et al., 1996
), the
Ras-Raf pathway (Finco and Baldwin, 1993
; Li and Sedivy, 1993
), PKC-
(Diaz-Meco et al., 1994
), double-stranded RNA-dependent kinase (Yang et al., 1995
),
mitogen-activated protein kinase/extracellular response
kinase (ERK)-1 (Lee et al., 1997
), MAP3K-related kinase
(Malinin et al., 1997
), and I
B kinase (Zandi et al., 1997
).
PKC-
was reported to be associated with I
-B
phosphorylation and subsequent NF-
B activation (Diaz-Meco et al.,
1993
; Dominguez et al., 1993
; Diaz-Meco et al., 1994
;
Folgueira, 1996). Along with the evidence in this report
that 3D COL modulated cellular level of I
-B
(Fig. 2 B),
is our previous finding that PKC-
activity is induced under the same condition (Xu and Clark, 1997
). Therefore, an
attractive hypothesis would be that signals from 3D COL
are transmitted into the nucleus in part through a PKC-
/I
-B
pathway.
Toward investigating the role of NF-B in
2 gene expression, we first questioned whether 3D COL induced
2
transcription. Although several groups have observed 3D
COL induction of
2 mRNA and/or protein steady-state
levels (Klein et al., 1991
; Langholz et al., 1995
; Xu and
Clark, 1996
), it was not known whether the regulation occurs at transcriptional level. In this report an upstream region between
549 and
351 bp was identified to confer the 3D COL indicibility of
2 promoter (Figs. 4 and 5). We
confirmed the presence of a general silencer between
92
and
122 bp that suppresses the basal integrin
2 promoter activity as proposed previously (Zutter et al., 1995b
).
The stimulated expression by 3D COL was mediated by
sequences upstream of this region, suggesting that 3D
COL could regulate
2 gene transcription in a DNA sequence-dependent manner, probably by releasing the negative impact of the silencer present between
92 and
122 bp on the promoter activity. A further study of the
DNA binding pattern in the 3D COL-responsive region from
549 to
351 bp revealed that there were three
DNA sequence-specific protein complexes (Fig. 7). Although the regulation of promoter activity by 3D ECM has
not been studied as extensively as those by soluble factors,
a similar study on
-casein gene promoter activity conducted by Schmidhauser et al. (1992)
identified a 160-bp
region in the promoter responsible for its activation by 3D
matrigel. In another study, the promoter of TGF-
1 was
found to be downregulated by 3D matrigel (Streuli et al.,
1993
). The involvement of NF-
B activity in
2 promoter
activity was investigated using two inhibitors, SN50, a peptide inhibitor for NF-
B nuclear translocation (Lin et al.,
1995b
), and I
B-
32, 36, a stable I
B-
that serves to inhibit
NF-
B. Interestingly, whereas NF-
B activity was consistently found to be required for full activation of integrin
2
expression at levels of mRNA steady-state (Fig. 3 B), protein (Fig. 8 C), and transcription (Fig. 6), as well as for
2
promoter-DNA protein complex formation (Fig. 7 B), there
was no evidence for direct physical involvement of NF-
B in
2 promoter; this observation is based on competition
experiments with unlabeled NF-
B consensus sequence
and supershift assay with antibodies against NF-
B proteins (unpublished laboratory data). The observation was
further supported by our failure to find any functional activity of a near-perfect NF-
B consensus site located in the
region between
549 and
351 bp of
2 promoter as
judged by two sets of experiments: gel mobility shift assay
with the synthetic oligonucleotides based on the
2 NF-
B-like sequence, and functional assay with the site inserted into a reported gene vector (unpublished laboratory data). Taken together, these observations suggest an
indirect regulatory mechanism by which NF-
B directs the
synthesis of another transcription factor that in turn activates the integrin
2 promoter. Among many genes known
to be mediated by NF-
B are these transcription factors,
c-myc (Duyao et al., 1990
; LaRosa et al., 1994
), interferon
regulatory factor 1 (Fujita et al., 1989
; Harada et al., 1994
),
RelA (Ueberla et al., 1993
), p50 (Ten et al., 1992
), and
-1
acid glycoprotein/enhancer-binding protein (Lee et al.,
1996
). In fact, we found that 3D COL-induced integrin
2
mRNA expression requires newly synthesized protein (Xu
and Clark, 1997
), an observation in accord with the synthesis of an intermediary transcription factor induced by
NF-
B. Further studies will be required to address the
identity of these three DNA-protein complexes, their regulation by 3D COL, and their functional roles in integrin
2 gene expression.
The physiological role of NF-B family proteins is under
intensive study. NF-
B has been implicated in biological
and pathological processes such as cell death (Grimm et al.,
1996
; Wu et al., 1996
), angiogenesis (Shono et al., 1996
),
rheumatoid arthritis (Yang et al., 1995
), and human cutaneous T lymphoma formation (Thakur et al., 1994
). The
appropriate regulation of NF-
B activity seems critical for
proper biological function. For example, NF-
B activity is
required for the H2O2-induced tube formation in human
microvascular endothelial cells grown on 3D COL (Shono
et al., 1996
) and antitumor properties of antineoplastic agent
taxol in macrophages (Hwang and Ding, 1995
). On the
other hand, the constitutive NF-
B activation in I
B
-/-
transgenic mice causes skin defects (Beg et al., 1995
) and
severe widespread dermatitis (Klement et al., 1996
). The
important role of NF-
B in mediating reorganization and
contraction of 3D COL as reported here adds another potential biological function of NF-
B. The inhibition of NF-
B
activity, which led to inhibited expression of integrin
2 after 3D COL stimulation, correlated with the inability of
cells to contract collagen gel (Fig. 8). NF-
B, therefore, may
regulate 3D COL contraction through cell surface expression of
2
1 level. However, it must be noted that other
possibilities cannot be ruled out. For example, we found that the presence of
2
1 alone, although neccessary, was
not sufficient for the reorganization and contraction of collagen matrices (unpublished laboratory data), suggesting
that the availability of
2
1 receptor and the
2
1-elicited
second mesenger pathway probably present two separate
control levels for 3D COL contraction. Furthermore, the
inhibition of NF-
B by SN50 also decreased the 3D COL-
induced expression of MMP-1 (Fig. 3 B), a protein involved in tissue remodeling. Additionally, NF-
B is strongly
implicated in the transcriptional regulation of several
growth factors and cytokine genes including interferon-
,
IL-1
, IL-2, IL-6, TNF-
and TGF-
1 (for review see Baldwin, 1996
), which might offer another interpretation on
the mechanism whereby NF-
B modulates tissue remodeling. The essential role for NF-
B in reorganization and contraction of COLs as reported here may present a potentially important nuclear regulatory site for tissue remodeling.
![]() |
Footnotes |
---|
Received for publication 17 July 1997 and in revised form 29 November 1997.
Funding for this work was provided by National Institutes of Health grant AG10114309 (R.A.F. Clark). J. Xu was supported by funding from the Dermatology Foundation and the School of Medicine, SUNY at Stony Brook.We thank Dr. M. Simon for adult human dermal fibroblasts, Dr. Y. Takada for human 2 cDNA probe, and Dr. W. Greene for I
B-
plasmids.
![]() |
Abbreviations used in this paper |
---|
BIM, bisindolylmaleimide GF
109203X;
COL, collagen lattice;
ECM, extracellular matrix;
IB, inhibitor
for NF-
B;
IL, interleukin;
MMP-1, type I matrix metalloproteinase;
NF-
B, nuclear factor
B;
PKC, protein kinase C;
3D, three-dimensional;
TGF-
, transforming growth factor-
;
TNF, tumor necrosis factor.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. |
Ahlen, K., and
R. Kristofer.
1994.
Platelet-derived growth factor-BB stimulates
synthesis of the integrin ![]() |
2. |
Baeuerle, P.A., and
D. Baltimore.
1996.
NF-![]() |
3. |
Baldwin, A.S. Jr..
1996.
The NF-![]() ![]() |
4. |
Beg, A.A., and
A.S. Baldwin Jr..
1993.
The I![]() ![]() |
5. |
Beg, A.A.,
W.C. Sha,
R.T. Bronson, and
D. Baltimore.
1995.
Constitutive NF-![]() ![]() ![]() |
6. |
Brown, K.,
S. Park,
T. Kanno,
G. Franzoso, and
U. Siebenlist.
1993.
Mutual regulation of the transcriptional activator NF-![]() ![]() ![]() |
7. | Caron, J.M.. 1990. Induction of albumin gene transcription in hepatocytes by extracellular matrix proteins. Mol. Cell. Biol. 10: 1239-1243 |
8. | Chan, B.M., N. Matsuura, Y. Takada, B.R. Zetter, and M.E. Hemler. 1991. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science. 251: 1600-1601 |
9. |
Chan, B.M.,
M.J. Elice,
E. Murphy, and
M.E. Hemler.
1992.
Adhesion of vascular cell adhesion molecule 1 and fibronectin. Comparison of ![]() ![]() ![]() ![]() |
10. |
Chiao, P.J.,
S. Miyamoto, and
I.M. Verma.
1994.
Autoregulation of I![]() ![]() |
11. | Chromczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159 |
12. |
Cordle, S.R.,
R. Donald,
M.A. Read, and
J. Hawiger.
1993.
Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-rel and related NF-![]() |
13. |
Diaz-Meco, M.T.,
E. Berra,
M.M. Municio,
L. Sanz,
J. Lozano,
I. Dominguez,
V. Diaz-Golpe,
M.T.L. de Lera,
J. Alcami,
C.V. Paya, et al
.
1993.
A dominant negative protein kinase C ![]() ![]() |
14. |
Diaz-Meco, M.T.,
I. Dominguez,
L. Sanz,
P. Dent,
J. Lozano,
M.M. Municio,
E. Berra,
R.T. Hay,
T.W. Sturgill, and
J. Moscat.
1994.
![]() ![]() ![]() |
15. | DiPersio, C.M., D.A. Jackson, and K. Zaret. 1991. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol. Cell. Biol. 11: 4405-4414 |
16. |
Doerr, M.E., and
J.I. Jones.
1996.
The roles of integrins and extracellular matrix
proteins in the insulin-like growth factor 1-stimulated chemotaxis of human
breast cancer cells.
J. Biol. Chem.
271:
2443-2447
|
17. |
Dominguez, I.,
L. Sanz,
F. Arenzana-Seisdedos,
M. Diaz-Meco,
J.-L. Virelizier, and
J. Moscat.
1993.
Inhibition of protein kinase C ![]() ![]() |
18. |
Duyao, M.P.,
A.J. Buckler, and
G.E. Sonenshein.
1990.
Interaction of an NF-![]() |
19. | Eckes, B., C. Mauch, G. Huppe, and T. Krieg. 1993. Downregulation of collagen synthesis in fibroblasts within three-dimensional collagen lattices involves transcriptional and posttranscriptional mechanisms. FEBS (Fed. Eur. Biochem. Soc.) Lett. 318: 129-133 . |
20. | Elices, M.J., and M.E. Hemler. 1989. The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc. Natl. Acad. Sci. USA. 86: 9906-9910 [Abstract]. |
21. | Elices, M.J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M.E. Hemler, and R.R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60: 577-584 |
22. |
Finco, T.S., and
A.S. Baldwin.
1993.
![]() ![]() |
23. |
Folgueira, L.,
J.A. McElhinny,
G.D. Bren,
W.S. MacMorran,
M.T. Diaz-Meco,
J. Moscat, and
C.V. Paya.
1996.
Protein kinase C-![]() ![]() |
24. |
Fujii, K.,
N. Dousaka-Nakajima, and
S. Imamura.
1995.
Epidermal growth factor enhancement of HSC-1 human cutaneous squamous carcinoma cell adhesion and migration on type I collagen involves selective up-regulation of
![]() ![]() |
25. |
Fujita, T.,
L.F.L. Reis,
N. Watanabe,
Y. Kimura, and
T. Taniguchi.
1989.
Induction of the transcription factor IRF-1 and IFN-![]() |
26. |
Grimm, S.,
M.K.A. Bauer,
P.A. Baeuerle, and
K. Schulze-Osthoff.
1996.
Bcl-2 down-regulates the activity of transcription factor NF-![]() |
27. | Grinnell, F.. 1994. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124: 401-404 |
28. | Harada, H., E.-I. Takahashi, S. Itoh, and K. Harada. 1994. Structure and regulation of the human interferon regulatory factor (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 14: 1500-1509 [Abstract]. |
29. |
Henkel, T.,
T. Machleidt,
I. Alkalay,
M. Kronke,
Y. Ben-Neriah, and
P.A. Baeuerle.
1993.
Rapid proteolysis of I![]() ![]() ![]() |
30. |
Hwang, S., and
A. Ding.
1995.
Activation of NF-![]() |
31. |
Imbert, V.,
R.A. Rupec,
A. Livolsi,
H.L. Pahl,
E.B.-M. Traenckner,
C. Mueller,
D. Farahifar,
B. Rossi,
P. Auberger,
P.A. Baeuerle, and
J.-F. Peyron.
1996.
Tyrosine phosphorylation of I![]() ![]() ![]() ![]() ![]() |
32. |
Keely, P.J.,
A.M. Fong,
M.M. Zutter, and
S.A. Santoro.
1995.
Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of
antisense ![]() |
33. |
Kirchhofer, D.,
L.R. Languino,
E. Ruoslahti, and
M.D. Pierschbacher.
1990.
![]() ![]() |
34. |
Kitajima, I.,
T. Shinohara,
J. Bilakovics,
D. Brown,
X. Xu, and
M. Nerenberg.
1992.
Ablation of transplanted HTLV-I tax transformed tumors in mice by
antisense inhibition of NF-![]() |
35. |
Klein, C.E.,
D. Dressel,
T. Steinmayer,
C. Mauch,
B. Eckes,
T. Krieg,
R.B. Bankert, and
L. Weber.
1991.
Integrin ![]() ![]() |
36. |
Klement, J.F.,
N.R. Rice,
B.D. Car,
S.J. Abbondanzo,
G.D. Powers,
H. Bhatt,
C.-H. Chen,
C.A. Rosen, and
C.L. Stewart.
1996.
I![]() ![]() ![]() |
37. | Koyama, H., E.W. Raines, K.E. Bornfeldt, J.M. Roberts, and R. Ross. 1996. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors. Cell. 87: 1069-1078 |
38. |
Kupper, T.S., and
T.A. Ferguson.
1993.
A potential pathophysiologic role for
![]() ![]() |
39. |
Langholz, O.,
D. Rockel,
C. Mauch,
E. Kozlowska,
I. Bank,
T. Krieg, and
B. Eckes.
1995.
Collagen and collagenase gene expression in three-dimensional
collagen lattices are differentially regulated by ![]() ![]() ![]() ![]() |
40. |
Languino, L.R.,
K.R. Gehlsen,
E. Wayner,
W.G. Carter,
E. Engvall, and
E. Ruoslahti.
1989.
Endothelial cells use ![]() ![]() |
41. |
LaRosa, F.A.,
J.W. Pierce, and
G.E. Sonensheim.
1994.
Differential regulation
of the c-myc oncogene promoter by the NF-![]() |
42. |
LeBail, O.,
R. Schmidt-Ullrich, and
A. Israel.
1993.
Promoter analysis of the
gene encoding the I![]() ![]() ![]() ![]() |
43. |
Lee, F.S.,
J. Hagler,
Z.J. Chen, and
T. Maniatis.
1997.
Activation of the I![]() ![]() |
44. |
Lee, Y.-M.,
L.-H. Miau,
C.-J. Chang, and
S.-C. Lee.
1996.
Transcriptional induction of the ![]() ![]() |
45. |
Li, S., and
J.M. Sedivy.
1993.
Raf-1 protein kinase activates the NF-![]() ![]() ![]() |
46. |
Lin, T.H.,
C. Rosales,
K. Mondal,
J.B. Bolen,
S. Haskill, and
R.L. Juliano.
1995a.
Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase.
J. Biol. Chem.
270:
16189-16197
|
47. |
Lin, Y.-Z.,
S. Yao,
R.A. Veach,
T.R. Torgerson, and
J. Hawiger.
1995b.
Inhibition of nuclear translocation of transcription factor NF-![]() |
48. | Liu, J.-K., C.M. DiPersio, and K.S. Zaret. 1991. Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. Mol. Cell. Biol. 11: 773-784 |
49. |
Lofquist, A.K.,
K. Mondal,
J.S. Morris, and
J.S. Haskill.
1995.
Transcription- independent turnover of I![]() ![]() ![]() ![]() |
50. |
Malinin, N.L.,
M.P. Boldin,
A.V. Kovalenko, and
D. Wallach.
1997.
MAP3K-related kinase involved in NF-![]() |
51. |
Narayanan, R.,
K.A. Higgins,
J.R. Perez,
T.A. Coleman, and
C.A. Rosen.
1993.
Evidence for differential function of the p50 and p65 subunits of NF-![]() |
52. |
Parry, G.C., and
N. Mackman.
1994.
A set of inducible genes expressed by activated human monocytic and endothelial cells contain ![]() |
53. |
Qwarnstrom, E.E.,
C.O. Ostberg,
G.L. Turk,
C.A. Richardson, and
K. Bomsztyk.
1994.
Fibronectin attachment activates the NF-![]() |
54. |
Riikonen, T.,
J. Westermarck,
L. Koivisto,
A. Broberg,
V.-M. Kahari, and
J. Heino.
1995a.
Integrin ![]() ![]() ![]() |
55. |
Riikonen, T.,
L. Koivisto,
P. Vihinen, and
J. Heino.
1995b.
Transforming growth factor-![]() ![]() ![]() |
56. |
Schiro, J.A.,
B.M.C. Chan,
W.T. Roswit,
P.D. Kassner,
A.P. Pentland,
M.E. Hemler,
A.Z. Eisen, and
T.S. Kupper.
1991.
Integrin ![]() ![]() |
57. |
Schmidhauser, C.,
G.F. Casperson,
C.A. Myers,
K.T. Sanzo,
S. Bolten, and
M.J. Bissell.
1992.
A novel transcriptional enhancer is involved in the prolactin-
and extracellular matrix-dependent regulation of ![]() |
58. |
Shono, T.,
M. Ono,
H. Izumi,
S.-I. Jimi,
K. Matsushima,
T. Okamoto,
K. Kohno, and
M. Kuwano.
1996.
Involvement of the transcription factor
NF-![]() |
59. |
Skinner, M.P.,
E.W. Raines, and
R. Ross.
1994.
Dynamic expression of ![]() ![]() ![]() ![]() ![]() ![]() |
60. |
Sokoloski, J.A.,
A.C. Sartorelli,
C.A. Rosen, and
R. Narayanan.
1993.
Antisense oligonucleotides to the p65 subunit of NF-![]() ![]() |
61. |
Streuli, C.,
C. Schmmidhauser,
M. Kobrin,
M. Bissell, and
R. Derynck.
1993.
Extracellular matrix regulates expression of the TGF-![]() |
62. |
Sun, S.-C.,
P.A. Ganchi,
D.W. Ballard, and
W.C. Greene.
1993.
NF-![]() ![]() ![]() |
63. |
Takada, Y., and
M.E. Hemler.
1989.
The primary structure of the VLA-2/collagen receptor ![]() |
64. |
Ten, R.M.,
C.V. Paya,
N. Israel,
O. LeBail, and
M.-G. Matteri.
1992.
The characterization of the promoter of the gene encoding the p50 subunit of NF-![]() |
65. |
Thakur, S.,
H.C. Lin,
W.T. Tseng,
S. Kumar,
R. Bravo,
F. Foss,
C. Gelinas, and
A. Rabson.
1994.
Rearrangement and altered expression of the NF![]() |
66. |
Traenckner, E.B.,
H.L. Pahl,
T. Henkel,
K.N. Schmidt,
S. Wilk, and
P.A. Baeuerle.
1995.
Phosphorylation of human I![]() ![]() ![]() |
67. |
Ueberla, K.,
Y.C. Lu,
E. Chung, and
W.A. Haseltine.
1993.
The NF-![]() |
68. |
Wang, C.-Y.,
M.W. Mayo, and
A.S. Baldwin Jr..
1996.
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-![]() |
69. |
Wu, M.,
H. Lee,
R.E. Bellas,
S.L. Schauer,
M. Arsura,
D. Katz,
M.J. FitzGerald,
T.L. Rothstein,
D.H. Sherr, and
G.E. Sonenshein.
1996.
Inhibition of
NF-![]() |
70. | Xu, J., and R.A.F. Clark. 1996. Extracellular matrix alters PDGF regulation of fibroblast integrins. J. Cell Biol. 132: 239-249 [Abstract]. |
71. |
Xu, J., and
R.A.F. Clark.
1997.
A three-dimensional collagen lattice induces
protein kinase C-![]() ![]() |
72. |
Xu, J.,
M.M. Zutter,
S. Santoro, and
R.A.F. Clark.
1996.
PDGF induction of ![]() ![]() |
73. |
Yang, J.,
J. Merin,
T. Nakano,
T. Kano,
Y. Kitade, and
T. Okamoto.
1995.
Inhibition of the DNA binding activity of NF-![]() |
74. | Yang, Y.L., L.F.L. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B.R.G. Williams, M. Aguet, and C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO (Eur. Mol. Biol. Organ.) J. 14: 6095-6106 [Abstract]. |
75. |
Ye, J.,
R.H. Xu,
J. Taylor-Papadimitriou, and
P.M. Pitha.
1996.
Sp1 binding
plays a critical role in Erb-B2- and v-ras-mediated downregulation of ![]() |
76. |
Zandi, E.,
D.M. Rothwarf,
M. Delhase,
M. Hayakawa, and
M. Karin.
1997.
The I![]() ![]() ![]() ![]() ![]() |
77. |
Zutter, M.M.,
S.A. Santoro,
A.S. Painter,
Y.L. Tsung, and
A. Gafford.
1994.
The human ![]() |
78. |
Zutter, M.M.,
S.A. Santoro,
W.D. Staatz, and
Y.L. Tsung.
1995a.
Re-expression of the ![]() ![]() |
79. |
Zutter, M.M.,
A.A. Painter,
W.D. Staatz, and
Y.L. Tsung.
1995b.
Regulation of
![]() |